313 related articles for article (PubMed ID: 25622278)
1. Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.
Ryan RE; Martin B; Mellor L; Jacob RB; Tawara K; McDougal OM; Oxford JT; Jorcyk CL
Cytokine; 2015 Mar; 72(1):71-85. PubMed ID: 25622278
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
3. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings.
Pan CM; Wang ML; Chiou SH; Chen HY; Wu CW
Oncotarget; 2016 Sep; 7(37):60395-60406. PubMed ID: 27486982
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons.
Chang SH; Hwang CS; Yin JH; Chen SD; Yang DI
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2306-25. PubMed ID: 25986861
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
[TBL] [Abstract][Full Text] [Related]
8. Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis.
Liu Q; Du Y; Li K; Zhang W; Feng X; Hao J; Li H; Liu S
Mediators Inflamm; 2017; 2017():3038514. PubMed ID: 28626343
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice.
Wong S; Botelho FM; Rodrigues RM; Richards CD
Lab Invest; 2014 Sep; 94(9):1003-16. PubMed ID: 24933422
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis.
Albasanz-Puig A; Murray J; Preusch M; Coan D; Namekata M; Patel Y; Dong ZM; Rosenfeld ME; Wijelath ES
Atherosclerosis; 2011 Jun; 216(2):292-8. PubMed ID: 21376322
[TBL] [Abstract][Full Text] [Related]
11. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
12. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.
Zhang F; Li C; Halfter H; Liu J
Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
15. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.
Smigiel JM; Parameswaran N; Jackson MW
Mol Cancer Res; 2017 Apr; 15(4):478-488. PubMed ID: 28053127
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways.
Wang H; Lei L; Hu J; Li Y
Exp Physiol; 2020 Jul; 105(7):1151-1158. PubMed ID: 32359099
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts.
Tu HJ; Lin TH; Chiu YC; Tang CH; Yang RS; Fu WM
J Cell Physiol; 2013 May; 228(5):983-90. PubMed ID: 23042533
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells.
Jorcyk CL; Holzer RG; Ryan RE
Cytokine; 2006 Mar; 33(6):323-36. PubMed ID: 16713283
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.
Wang ML; Pan CM; Chiou SH; Chen WH; Chang HY; Lee OK; Hsu HS; Wu CW
Cancer Res; 2012 Nov; 72(22):6051-64. PubMed ID: 23139208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]